Same Indication

Lisinopril vs Rituximab

Lisinopril vs Rituximab: Overview

This comparison examines the pharmacological differences between Lisinopril and Rituximab.

Mechanism of Action

Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Lisinopril — 12 hours; Rituximab — 22 days.

Chemical Properties

Molecular Formula: Lisinopril — C21H31N3O5.

Molecular Weight: Lisinopril — 405.4900 g/mol.

Type: Lisinopril — Small molecule; Rituximab — Antibody.